index - Plateforme d’immortalisation MyoLine – CRM Accéder directement au contenu

Dernières publications

Chiffres clés

Chargement de la page

Open Access

87 %

Mots clés

Exon-skipping Antisense morpholino Adhesion DsDNA break repair Mdx52 mice Coculture Lamin A/C nuclei Migration Eteplirsen Differentiation Lymphotoxin-β-receptor Conjugation Expanded repeats Becker muscular dystrophy Fear response DNM2 CXCR4 Drisapersen Centronuclear myopathy Alternative splicing Neuromuscular junction Gene therapy Autophagosome Folding-defective proteins DMD Emerin Dominant centronuclear myopathy CFTR correctors Muscle CMS Computer software Flavonoid Allele-specific silencing therapy Allele-specific silencing HDMD/Dmd-null mice Atrial cardiac defects Gut microbiota Dystrophin Mdx LRP4 Actin Machine learning Human Adeno-associated viral vector Endocytosis Skeletal muscle Fibrosis Cell-penetrating peptide Lamina-associated domain Clinical trial candidate screening Immortalized dystrophic canine myoblast RNA interference Insulin 3D co-culture Myotonic dystrophy LTβR ICU-acquired weakness MSCs Exon skipping CLS Gel electrophoresis Gene network analysis MT RNA/DNA Editing Antisense oligonucleotide Cell biology Immortalisation KLF15 Exon Skipping Exondys 51 Duchenne muscular dystrophy Cell Therapy Developmental biology Glucose CTG⋅CAGn repeat Human muscle stem/progenitor cells CDNA synthesis Dynamin 2 Autophagy FoxO Human artificial chromosomes Laminographie Duchenne Muscular Dystrophy Fibroblast ITSN1 Acetylcholine receptor subunit epsilon Motor neuron Canine X-linked muscular dystrophy in Japan CXMD J Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS FSHD Chromatin DM1 myoblasts Glucocorticoid-induced muscle atrophy Bile acid BAF Myogenesis Myotube BMD CRISPR/Cas9 CXCL12 Gene Therapy